Cost-Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysia

Nor Azmaniza Azizam ^1,2 * , Aniza Ismail ³, Saperi Sulong ³, Norazirah Md Nor ⁴

Cited by CrossRef:

1- Chin H, Jamil A, Muhamad Sarkan M, Tang J. Comparison of Minimal Erythema Dose Between Affected and Unaffected Skin in Vitiligo Patients With Fitzpatrick Skin Phototypes III, IV, and V. Photoderm Photoimm Photomed. 2025;41(2) [Crossref]

2- Nowowiejska J, Baran A, Flisiak I. Mutual Relationship Between Sleep Disorders, Quality of Life and Psychosocial Aspects in Patients With Psoriasis. Front Psychiatry. 2021;12 [Crossref]

3- Nguyen H, Vu A, Pham N, Tran T, Pham N, Bui H, Pham T, Dinh V, Bui Y, Vu T. Comorbidity Burden and Treatment Patterns of Psoriasis in Vietnam: Real-World Data from the EXPAND Study. Dermatol Ther (Heidelb). 2023;13(12):3193 [Crossref]

4- Ponvel P, Shahar S, Singh D, Ludin A, Rajikan R, Rajab N, Ai-Vyrn C, Din N, Ibrahim N, Subramaniam P, Haron H, Ismail A, Sharif R, Ramasamy K, Majeed A, Ali N, Mohamad M, Noah S, Ibrahim A, Safien A, Khalid N, Fadzil N, Mangialasche F, Kivipelto M. Multidomain Intervention for Reversal of Cognitive Frailty, Towards a Personalized Approach (AGELESS Trial): Study Design. JAD. 2021;82(2):673 [Crossref]

5- Azizam N, Hussain M, Nauenberg E, Ang W, Azzeri A, Smith J, Tian S. Cost-effectiveness analysis of biologic sequential treatments for moderate-to-severe psoriasis: A Malaysian healthcare system perspective. PLoS ONE. 2024;19(9):e0307234 [Crossref]

6- Ramadan F. Psoriasis: treatment modalities and the need for multidisciplinary care. British Journal of Healthcare Management. 2023;29(3):101 [Crossref]

Submit Your Paper Archive